Next Article in Journal
New Cytotoxic Cembranolides from the Soft Coral Lobophytum michaelae
Next Article in Special Issue
Toxicity of Cultured Bullseye Puffer Fish Sphoeroides annulatus
Previous Article in Journal
Recruitment of Glycosyl Hydrolase Proteins in a Cone Snail Venomous Arsenal: Further Insights into Biomolecular Features of Conus Venoms
Previous Article in Special Issue
Tetrodotoxin-Bupivacaine-Epinephrine Combinations for Prolonged Local Anesthesia
Mar. Drugs 2012, 10(2), 281-305; doi:10.3390/md10020281

Tetrodotoxin (TTX) as a Therapeutic Agent for Pain

* ,
 and *
Received: 30 December 2011 / Revised: 19 January 2012 / Accepted: 19 January 2012 / Published: 31 January 2012
(This article belongs to the Special Issue Tetrodotoxin)
View Full-Text   |   Download PDF [1168 KB, updated 24 February 2015; original version uploaded 24 February 2015]   |   Browse Figures
Abstract: Tetrodotoxin (TTX) is a potent neurotoxin that blocks voltage-gated sodium channels (VGSCs). VGSCs play a critical role in neuronal function under both physiological and pathological conditions. TTX has been extensively used to functionally characterize VGSCs, which can be classified as TTX-sensitive or TTX-resistant channels according to their sensitivity to this toxin. Alterations in the expression and/or function of some specific TTX-sensitive VGSCs have been implicated in a number of chronic pain conditions. The administration of TTX at doses below those that interfere with the generation and conduction of action potentials in normal (non-injured) nerves has been used in humans and experimental animals under different pain conditions. These data indicate a role for TTX as a potential therapeutic agent for pain. This review focuses on the preclinical and clinical evidence supporting a potential analgesic role for TTX. In addition, the contribution of specific TTX-sensitive VGSCs to pain is reviewed.
Keywords: tetrodotoxin; TTX; TTX-sensitive voltage-gated sodium channels; pain; neuropathic pain tetrodotoxin; TTX; TTX-sensitive voltage-gated sodium channels; pain; neuropathic pain
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Nieto, F.R.; Cobos, E.J.; Tejada, M.Á.; Sánchez-Fernández, C.; González-Cano, R.; Cendán, C.M. Tetrodotoxin (TTX) as a Therapeutic Agent for Pain. Mar. Drugs 2012, 10, 281-305.

AMA Style

Nieto FR, Cobos EJ, Tejada MÁ, Sánchez-Fernández C, González-Cano R, Cendán CM. Tetrodotoxin (TTX) as a Therapeutic Agent for Pain. Marine Drugs. 2012; 10(2):281-305.

Chicago/Turabian Style

Nieto, Francisco Rafael; Cobos, Enrique José; Tejada, Miguel Ángel; Sánchez-Fernández, Cristina; González-Cano, Rafael; Cendán, Cruz Miguel. 2012. "Tetrodotoxin (TTX) as a Therapeutic Agent for Pain." Mar. Drugs 10, no. 2: 281-305.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert